The national study of over 60,000, researchers concluded that asthma symptoms worsened in the six months following a COVID-19 infection.
Common theme of hope resonates at inaugural CHOC/UCI Rare Disease Symposium and Family Conference
At the inaugural CHOC/UCI Rare Disease Conference, providers discussed plans for extended research, collaboration and treatment strategies.
Bounce house injuries continue to jump
A CHOC-led study on the frequency of bounce house injuries reveals the safety concerns and the need for prevention tactics.
Medical device research leads to improved neonatal care
A partnership between CHOC and Masimo has developed technology to noninvasively monitor blood oxygen and hemoglobin levels in newborns.
Innovative protocol studies treatment for rare pediatric PTCL and NK/T-Cell lymphoma
CHOC helps develop innovative treatment protocols for PTCL and NK/T-cell lymphoma, which are now available for patients.
Rare disease leaders to speak at inaugural symposium and family conference on March 11
The Inaugural CHOC and UCI Rare Disease Symposium & Family Conference will take place on Friday, March 11, 2022, from 10:30 a.m. to 3 p.m.
